Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Nevirapine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Multiple Dose BE Study With Nevirapine 400mg PR Tablets
Details : Viramune (Nevirapine) is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of HIV-1.
Product Name : Viramune
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 28, 2014
Lead Product(s) : Nevirapine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
